Atlas Trials

Study of rESP Injection for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis

Clinical trial NCT03950687 · UNKNOWN

Trial details

NCT number
NCT03950687
Sponsor
Shenyang Sunshine Pharmaceutical Co., LTD.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Renal Failure With Hemodialysis
Start date
2019-06-24
Primary completion
2020-06-30
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.